Phillip Minton M.D.

Posts Tagged ‘cancer treatment’

The High Cost of Conventional Cancer Treatment

In cancer, non-hodgkins lymphoma on September 1, 2013 at 5:18 pm

Conventional medical care in America is shockingly expensive. If you have ever had the sad experience of being on the receiving end of hospital, laboratory, or medical office bills that are not covered by some government or private program, you know what I mean. How much do you think a chest x-ray would cost? Thousands are done daily, and it is an old technology. It shouldn’t cost that much, don’t you think? Would twenty dollars be fair? as a medical doctor I would think so, and as it turns out, so does Medicare. Medicare allows hospitals to charge them about $20 for a routine CXR. But is that what a normal cash paying patient is billed? No way. How about nearly 15 times that much…around $280?

A recent article in Time Magazine detailed the plight of a man newly diagnosed with Non-Hodgkins Lymphoma, a very serious type of cancer. His medical insurance paid only up to $2,000 per day for hospital care. However it was nothing compared with the actual cost. Here are some of the charges he incurred:

 

Read the rest of this entry »

Advertisements

Endometrial Cancer Awareness for Women

In cancer, endometrial cancer on May 6, 2012 at 3:57 pm

Cancer that begins in the interior lining of the uterus is called endometrial cancer. Thousands of American women die each year from this kind of malignancy. Understanding endometrial cancer, and in particular its warning signs, is of great importance to all women. The following provides  a succinct overview.

A guide to endometrial cancer
Published May 05, 2012
NewsCore

Endometrial cancer begins in the lining of the uterus, a woman’s hollow pelvic organ that fosters fetal development. Genetic mutation causes abnormal, cancerous cell growth, developing into a tumor. According to the American Cancer Society, approximately 47,130 new cases of endometrial cancer will be diagnosed and 8,010 women will die from it in 2012.
Keep reading…

New Immune Therapy Cancer Treatment Drug Approved

In immune system, prostate cancer on June 15, 2011 at 9:06 am

For nearly a decade now I have written intermittently on the progress of the Dendreon Corporation, as it labors to develop cancer treatment drugs that use the immune system to kill living cancer cells. The FDA recently approved their flagship drug, Provenge, as an approved treatment for prostate cancer. Keep reading…